FDA Approved: ALHEMO — Original Application (Novo Nordisk)

View source ↗

Summary

The FDA approved ALHEMO (concizumab) from Novo Nordisk based on the original application, intended to prevent bleeding episodes in patients with hemophilia A or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ALHEMO (Concizumab)

Snippet

ORIG AP for ALHEMO (CONCIZUMAB)